Why has Outcome Health's patient education tablet usage dropped 30% in the last month across oncology practices?

Introduction

The recent 30% drop in Outcome Health's patient education tablet usage across oncology practices is a significant issue that requires immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term and long-term implications for the product and its users.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might have been a recent product update. Has there been any significant change to the tablet software or content in the last 1-2 months?

Why it matters: Recent changes could directly impact usage patterns. Expected answer: Yes, there was a major UI overhaul. Impact on approach: If confirmed, we'd focus on usability issues and user feedback.

• Considering user segments, I'm curious about the distribution of the drop. Is the 30% decrease uniform across all oncology practices, or are some more affected than others?

Why it matters: Helps identify if the issue is systemic or localized. Expected answer: The drop varies, with some practices experiencing up to 50% decrease. Impact on approach: Uneven distribution would lead us to investigate practice-specific factors.

• Thinking about the metric itself, I'm wondering about its components. Has there been any change in how tablet usage is measured or reported in the last month?

Why it matters: Ensures we're comparing apples to apples in our data analysis. Expected answer: No changes in measurement or reporting. Impact on approach: If changed, we'd need to recalibrate our analysis based on the new methodology.

• Considering external factors, I'm curious about any recent changes in oncology treatment protocols or guidelines. Have there been any significant updates that might affect how patients interact with educational content?

Why it matters: External changes could influence the perceived value of the tablet content. Expected answer: No major changes in treatment protocols. Impact on approach: If there were changes, we'd need to assess our content's relevance and alignment with new guidelines.